Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

796 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.
Todt D, François C, Anggakusuma, Behrendt P, Engelmann M, Knegendorf L, Vieyres G, Wedemeyer H, Hartmann R, Pietschmann T, Duverlie G, Steinmann E. Todt D, et al. Among authors: wedemeyer h. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2132-9. doi: 10.1128/AAC.02427-15. Print 2016 Apr. Antimicrob Agents Chemother. 2016. PMID: 26787701 Free PMC article.
Hepatitis B virus: where are we and where are we going?
Manns MP, Hadem J, Wedemeyer H. Manns MP, et al. Among authors: wedemeyer h. Methods Mol Med. 2004;96:415-43. doi: 10.1385/1-59259-670-3:415. Methods Mol Med. 2004. PMID: 14762285 Review. No abstract available.
Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H. Wiegand J, et al. Among authors: wedemeyer h. Hepatology. 2004 Jul;40(1):98-107. doi: 10.1002/hep.20291. Hepatology. 2004. PMID: 15239091
Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
Potthoff A, Deterding K, Trautwein C, Rifai K, Manns MP, Wedemeyer H. Potthoff A, et al. Among authors: wedemeyer h. Eur J Gastroenterol Hepatol. 2007 Oct;19(10):906-9. doi: 10.1097/MEG.0b013e3282094160. Eur J Gastroenterol Hepatol. 2007. PMID: 17873617
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.
Potthoff A, Wedemeyer H, Boecher WO, Berg T, Zeuzem S, Arnold J, Spengler U, Gruengreiff K, Kaeser T, Schuchmann M, Bergk A, Forestier N, Deterding K, Manns MP, Trautwein C; Hep-Net B/C Co-infection Study Group. Potthoff A, et al. Among authors: wedemeyer h. J Hepatol. 2008 Nov;49(5):688-94. doi: 10.1016/j.jhep.2008.03.028. Epub 2008 Apr 29. J Hepatol. 2008. PMID: 18490077 Clinical Trial.
796 results